SCHEMBL7938807

SCHEMBL7938807

O=c1cc(I)[nH]c2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.60
GAA P10253 3/20 0.60
KDM4E B2RXH2 7/20 0.56
HPGD P15428 6/20 0.56
LMNA P02545 5/20 0.56
CTSV O60911 4/20 0.56
CTSL P07711 4/20 0.56
HSD17B10 Q99714 4/20 0.56
TUBB4A P04350 1/20 0.56
TP53 P04637 1/20 0.56
TUBB P07437 1/20 0.56
TUBA3C P0DPH7 1/20 0.56
TUBA1B P68363 1/20 0.56
TUBA4A P68366 1/20 0.56
TUBB4B P68371 1/20 0.56
TUBB3 Q13509 1/20 0.56
TUBB2A Q13885 1/20 0.56
TUBB8 Q3ZCM7 1/20 0.56
TUBA3E Q6PEY2 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9163258 0.75 CYP1A2 (0.60) CYP1A2GAAKDM4EHPGDLMNA
SCHEMBL30199901 0.75 GAA (0.60) CYP1A2GAAKDM4EHPGDLMNA
SCHEMBL527043 0.75 CYP1A2 (1.00) CYP1A2GAAKDM4EHPGDLMNA
SCHEMBL10070259 0.75 CYP1A2 (0.60) CYP1A2GAAKDM4EHPGDLMNA
SCHEMBL19751533 0.75 CYP1A2 (0.62) CYP1A2GAAKDM4EHPGDLMNA
SCHEMBL7815453 0.75 CYP1A2 (0.60) CYP1A2GAAKDM4EHPGDLMNA
SCHEMBL6667751 0.75 GAA (0.60) CYP1A2GAAKDM4EHPGDLMNA
SCHEMBL4741376 0.75 GAA (0.60) CYP1A2GAAKDM4EHPGDLMNA
SCHEMBL18995263 0.75 CYP1A2 (0.60) CYP1A2GAAKDM4EHPGDLMNA
SCHEMBL29411863 0.72 HPGD (1.00) KDM4EHPGDLMNACTSVCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11744150-B2 Synthesis of aza-acenes as novel n-type materials for organic electronics UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2023-08-29 US disclosed
US-20130187136-A1 SYNTHESIS OF AZA-ACENES AS NOVEL N-TYPE MATERIALS FOR ORGANIC ELECTRONICS UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2013-07-25 US disclosed
US-6248739-B1 DNA POLYMERASE INHIBITORS EFFECTIVE AGAINST HERPESVIRUSES PHARMACIA & UPJOHN COMPANY 2001-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130187136-A1 SYNTHESIS OF AZA-ACENES AS NOVEL N-TYPE MATERIALS FOR ORGANIC ELECTRONICS ACE2, ACE, AZI2 CYP1A2 151/4885GAA 1806/4885KDM4E 298/4885
US-11744150-B2 Synthesis of aza-acenes as novel n-type materials for organic electronics ACE2, ACE, AZI2 CYP1A2 151/4885GAA 1806/4885KDM4E 298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.